15% of hospitalized COVID-19 patients can’t take Paxlovid: study

While often the antiviral of choice among high-risk patients, a new study found nearly 15 percent of 62,525 hospitalized COVID-19 patients had a medical contraindication to Paxlovid's antiviral combination of nirmatrelvir and ritonavir.

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive